October 9th RBC Capital: Abbott Laboratories' target price has been raised from $125 to $130, maintaining an "outperform" rating.
RBC Capital上调雅培目标价至130美元
RBC Capital raised abbott laboratories' target price to $130.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.